BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sivasudhan E, Blake N, Lu ZL, Meng J, Rong R. Dynamics of m6A RNA Methylome on the Hallmarks of Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:642443. [PMID: 33869193 DOI: 10.3389/fcell.2021.642443] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Sivasudhan E, Blake N, Lu Z, Meng J, Rong R. Hepatitis B Viral Protein HBx and the Molecular Mechanisms Modulating the Hallmarks of Hepatocellular Carcinoma: A Comprehensive Review. Cells 2022;11:741. [PMID: 35203390 DOI: 10.3390/cells11040741] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
2 Gungor MZ, Uysal M, Senturk S. The Bright and the Dark Side of TGF-β Signaling in Hepatocellular Carcinoma: Mechanisms, Dysregulation, and Therapeutic Implications. Cancers (Basel) 2022;14:940. [PMID: 35205692 DOI: 10.3390/cancers14040940] [Reference Citation Analysis]
3 Guo L, Yang H, Zhou C, Shi Y, Huang L, Zhang J. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy. Front Immunol 2021;12:773570. [PMID: 34956201 DOI: 10.3389/fimmu.2021.773570] [Reference Citation Analysis]
4 Qu N, Bo X, Li B, Ma L, Wang F, Zheng Q, Xiao X, Huang F, Shi Y, Zhang X. Role of N6-Methyladenosine (m6A) Methylation Regulators in Hepatocellular Carcinoma. Front Oncol 2021;11:755206. [PMID: 34692544 DOI: 10.3389/fonc.2021.755206] [Reference Citation Analysis]